Evidence map›Paper›PMID 36278093›Full record

ArticleACS omega2022

ACE2 and LOX Enzyme Inhibitions of Different Lavender Essential Oils and Major Components Linalool and Camphor.

Sevde Nur Biltekin, Ayşe Esra Karadaǧ, Betül Demirci, Fatih Demirci

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Foods (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Article
  7. Viruses · 2023
    Article
  8. Review
  9. ACS omega · 2023
    Article
  10. Hydroxypropyl-β-Cyclodextrin-BasedAntioxidants (Basel, Switzerland) · 2023
    Article
  11. Article
  12. In Vitro Antiviral Evaluations of ColdmixCurrent issues in molecular biology · 2023
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Sevde Nur BiltekinDepartment of Pharmaceutical Microbiology, School of Pharmacy, Istanbul Medipol University, Beykoz, Istanbul 34810, Turkey.ORCID https://orcid.org/0000-0003-1896-2729
Ayşe Esra KaradaǧDepartment of Pharmacognosy, School of Pharmacy, Istanbul Medipol University, Beykoz, Istanbul 34810, Turkey.ORCID https://orcid.org/0000-0002-3412-0807
Betül DemirciDepartment of Pharmacognosy, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey.
Fatih DemirciDepartment of Pharmacognosy, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey.ORCID https://orcid.org/0000-0003-1497-3017
Anadolu University · TRIstanbul Medipol University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this present study,

Identifiers

PMID36278093
PMCPMC9583641
OpenAlexW4302023451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.